CLINICAL_TRIALS trial_result · 2024-01-31

Clinical Trial Update: Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML>60a [Phase 3]

Phase 3 trial comparing the OSHO protocol to a standard arm in adults over 60 with acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Leipzig | Conditions: Acute Myeloid Leukaemia | Phase 3 | Status: COMPLETED